Skip to content

Therapeutic areas

Nine research lines. One scientific focus.

Our investigators cover a broad multi-therapeutic portfolio, anchored by deep experience in tropical and infectious disease.

Members of the Allied research team reviewing study data in the site's meeting room.

Principal Investigators

  • 01

    Pulmonology

    • Jorge Ahumada
    • Richard Mulett
  • 02

    Nephrology

    • Roberto Acosta-Madiedo
  • 03

    Internal Medicine

    • Roberto Acosta-Madiedo
  • 04

    Cardiology

    • Jose Alvarado
  • 05

    Rheumatology

    • Jesús Godoy
  • 06

    Orthopaedics

    • Carlos Encinales
  • 07

    Oncology

    • Oscar Madiedo
  • 08

    Infectious Diseases

    • Dinno Fernández
  • 09

    Hematology

    • Alexander Ariza

Where we are strongest

Tropical & infectious disease.

Barranquilla sits in an endemic zone for dengue, Zika and chikungunya. That is not a marketing line — it is the epidemiology of the region, and it means naive and exposed populations are reachable for vaccine and therapeutic studies without importing a cohort.

Our investigators have published on:

  • Dengue and Zika vaccine research
  • Congenital Zika syndrome
  • Neutralizing antibody response
  • Chronic arthritis associated with chikungunya

We also work across HIV, tuberculosis and hepatitis.

  • Dengue
  • Zika
  • Chikungunya
  • HIV
  • Tuberculosis
  • Hepatitis
Allied laboratory professional using a pipette inside a biosafety cabinet.